Michael Ulz
Stock Analyst at Morgan Stanley
(2.66)
# 2,915
Out of 4,988 analysts
590
Total ratings
42.4%
Success rate
1.1%
Average return
Main Sectors:
Stocks Rated by Michael Ulz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Reiterated: Hold | $300 | $239.56 | +25.23% | 48 | Sep 11, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $45 → $36 | $17.11 | +110.40% | 26 | Sep 9, 2026 | |
| IONS Ionis Pharmaceuticals | Rated: Buy | $110 → $104 | $44.44 | +134.02% | 40 | Sep 9, 2026 | |
| GUTS Fractyl Health | Reiterated: Hold | $2 | $0.60 | +233.33% | 19 | Sep 1, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $120 | $66.48 | +80.51% | 28 | Aug 31, 2026 | |
| RYTM Rhythm Pharmaceuticals | Reiterated: Buy | $150 | $97.71 | +53.52% | 22 | Aug 24, 2026 | |
| CABA Cabaletta Bio | Rated: Buy | $13 | $2.55 | +409.80% | 22 | Aug 17, 2026 | |
| AARD Aardvark Therapeutics | Rated: Sell | $3 | $5.38 | -44.24% | 9 | Aug 12, 2026 | |
| KYTX Kyverna Therapeutics | Rated: Buy | $33 | $7.13 | +362.83% | 24 | Aug 12, 2026 | |
| RCKT Rocket Pharmaceuticals | Rated: Hold | $5 | $3.37 | +48.37% | 19 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $32 | $12.20 | +162.30% | 34 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $23 → $20 | $8.06 | +148.14% | 16 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $5 | $3.11 | +60.77% | 13 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $150 → $137 | $91.83 | +49.19% | 25 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $25 | $20.11 | +24.32% | 31 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $27 → $25 | $10.60 | +135.85% | 24 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $95 | $28.99 | +227.70% | 25 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.6793 | +194.42% | 15 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.39 → $0.36 | $0.0001 | +359,900.00% | 13 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $9.09 | n/a | 8 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $2.53 | n/a | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $5 | $11.10 | n/a | 2 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $0.5 | $3.20 | n/a | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.88 | n/a | 18 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.32 | n/a | 3 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $40 | $28.55 | n/a | 12 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $60 → $23 | $10.25 | n/a | 2 | May 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $5.02 | n/a | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $3 | $27.00 | n/a | 2 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $63.94 | n/a | 15 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.35 | n/a | 12 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $38.41 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $32.09 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.51 | n/a | 13 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $340 | $990.32 | n/a | 6 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $69 → $60 | $16.03 | n/a | 2 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.44 | n/a | 3 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $3.60 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $37 | $17.62 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $12.79 | n/a | 1 | Aug 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $8 | $0.0001 | n/a | 4 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $40 | $3.55 | n/a | 5 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $5.33 | n/a | 1 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $150.11 | n/a | 1 | May 18, 2010 |
Alnylam Pharmaceuticals
Sep 11, 2026
Reiterated: Hold
Price Target: $300
Current: $239.56
Upside: +25.23%
Dyne Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $45 → $36
Current: $17.11
Upside: +110.40%
Ionis Pharmaceuticals
Sep 9, 2026
Rated: Buy
Price Target: $110 → $104
Current: $44.44
Upside: +134.02%
Fractyl Health
Sep 1, 2026
Reiterated: Hold
Price Target: $2
Current: $0.60
Upside: +233.33%
Arrowhead Pharmaceuticals
Aug 31, 2026
Reiterated: Buy
Price Target: $120
Current: $66.48
Upside: +80.51%
Rhythm Pharmaceuticals
Aug 24, 2026
Reiterated: Buy
Price Target: $150
Current: $97.71
Upside: +53.52%
Cabaletta Bio
Aug 17, 2026
Rated: Buy
Price Target: $13
Current: $2.55
Upside: +409.80%
Aardvark Therapeutics
Aug 12, 2026
Rated: Sell
Price Target: $3
Current: $5.38
Upside: -44.24%
Kyverna Therapeutics
Aug 12, 2026
Rated: Buy
Price Target: $33
Current: $7.13
Upside: +362.83%
Rocket Pharmaceuticals
Aug 12, 2026
Rated: Hold
Price Target: $5
Current: $3.37
Upside: +48.37%
Aug 11, 2026
Rated: Buy
Price Target: $25 → $32
Current: $12.20
Upside: +162.30%
Aug 7, 2026
Reiterated: Hold
Price Target: $23 → $20
Current: $8.06
Upside: +148.14%
Aug 7, 2026
Reiterated: Hold
Price Target: $4 → $5
Current: $3.11
Upside: +60.77%
Aug 6, 2026
Rated: Buy
Price Target: $150 → $137
Current: $91.83
Upside: +49.19%
Aug 6, 2026
Rated: Hold
Price Target: $25
Current: $20.11
Upside: +24.32%
Aug 6, 2026
Rated: Buy
Price Target: $27 → $25
Current: $10.60
Upside: +135.85%
Jul 30, 2026
Reiterated: Buy
Price Target: $95
Current: $28.99
Upside: +227.70%
Jun 3, 2026
Reiterated: Buy
Price Target: $2
Current: $0.6793
Upside: +194.42%
Jan 8, 2026
Downgraded: Sell
Price Target: $0.39 → $0.36
Current: $0.0001
Upside: +359,900.00%
Mar 11, 2025
Reiterated: Buy
Price Target: $5
Current: $9.09
Upside: n/a
Mar 6, 2025
Reiterated: Hold
Price Target: $5
Current: $2.53
Upside: n/a
Feb 11, 2025
Downgraded: Hold
Price Target: $20 → $5
Current: $11.10
Upside: n/a
Aug 13, 2024
Reiterated: Sell
Price Target: $0.5
Current: $3.20
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $1.88
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $0.32
Upside: n/a
Aug 22, 2023
Reiterated: Hold
Price Target: $40
Current: $28.55
Upside: n/a
May 22, 2023
Rated: Buy
Price Target: $60 → $23
Current: $10.25
Upside: n/a
Jan 27, 2023
Downgraded: Hold
Price Target: $3
Current: $5.02
Upside: n/a
Jan 5, 2022
Reiterated: Hold
Price Target: $7 → $3
Current: $27.00
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $63.94
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $1.35
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $38.41
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $32.09
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $14.51
Upside: n/a
Mar 4, 2021
Reiterated: Buy
Price Target: $340
Current: $990.32
Upside: n/a
Mar 1, 2021
Reiterated: Hold
Price Target: $69 → $60
Current: $16.03
Upside: n/a
Feb 16, 2021
Reiterated: Buy
Price Target: n/a
Current: $25.44
Upside: n/a
Jan 29, 2021
Reiterated: Buy
Price Target: $5
Current: $3.60
Upside: n/a
Jan 29, 2021
Reiterated: Buy
Price Target: $37
Current: $17.62
Upside: n/a
Aug 12, 2020
Initiated Coverage: Buy
Price Target: $45
Current: $12.79
Upside: n/a
Jul 30, 2020
Reiterated: Buy
Price Target: $15 → $8
Current: $0.0001
Upside: n/a
Mar 28, 2019
Reiterated: Hold
Price Target: $3 → $40
Current: $3.55
Upside: n/a
Oct 3, 2017
Rated: Buy
Price Target: n/a
Current: $5.33
Upside: n/a
May 18, 2010
Reiterated: Buy
Price Target: $28
Current: $150.11
Upside: n/a